These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Accelerated conversion of atrial fibrillation to normal sinus rhythm by pulmonary delivery of flecainide acetate in a porcine model. Verrier RL; Bortolotto AL; Silva BA; Marum AA; Stocco FG; Evaristo E; de Antonio VZ; Silva AC; Belardinelli L Heart Rhythm; 2018 Dec; 15(12):1882-1888. PubMed ID: 29958990 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary delivery of flecainide causes a rate-dependent predominant effect on atrial compared with ventricular depolarization duration revealed by intracardiac recordings in an intact porcine model. de Antonio VZ; Silva AC; Stocco FG; Silva BA; Marum AA; Bortolotto AL; Belardinelli L; Verrier RL J Cardiovasc Electrophysiol; 2018 Nov; 29(11):1563-1569. PubMed ID: 30106207 [TBL] [Abstract][Full Text] [Related]
4. Optimizing flecainide plasma concentration profile for atrial fibrillation conversion while minimizing adverse ventricular effects by rapid, low-dose intratracheal or intravenous administration. Marum AA; Silva BA; Bortolotto AL; Silva AC; de Antonio VZ; Belardinelli L; Verrier RL Int J Cardiol; 2019 Jan; 274():170-174. PubMed ID: 30217428 [TBL] [Abstract][Full Text] [Related]
5. Multimodal mechanisms and enhanced efficiency of atrial fibrillation cardioversion by pulmonary delivery of a novel flecainide formulation. Tessarolo Silva F; Pedreira GC; Medeiros SA; Bortolotto AL; Araujo Silva B; Hurrey M; Madhavapeddi P; Schuler C; Belardinelli L; Verrier RL J Cardiovasc Electrophysiol; 2020 Jan; 31(1):205-213. PubMed ID: 31749267 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary Delivery of Antiarrhythmic Drugs for Rapid Conversion of New-Onset Atrial Fibrillation. Verrier RL; Belardinelli L J Cardiovasc Pharmacol; 2020 Apr; 75(4):276-283. PubMed ID: 32032206 [TBL] [Abstract][Full Text] [Related]
7. If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation. Verrier RL; Bonatti R; Silva AF; Batatinha JA; Nearing BD; Liu G; Rajamani S; Zeng D; Belardinelli L Heart Rhythm; 2014 Dec; 11(12):2288-96. PubMed ID: 25111327 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation. Verrier RL; Sobrado MF; Pagotto VP; Kanas AF; Machado AD; Varone BB; Sobrado LF; Nearing BD; Zeng D; Belardinelli L Heart Rhythm; 2013 Nov; 10(11):1692-7. PubMed ID: 23933296 [TBL] [Abstract][Full Text] [Related]
9. The Selective Cardiac Late Sodium Current Inhibitor GS-458967 Suppresses Autonomically Triggered Atrial Fibrillation in an Intact Porcine Model. Carneiro JS; Bento AS; Bacic D; Nearing BD; Rajamani S; Belardinelli L; Verrier RL J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1364-9. PubMed ID: 26331943 [TBL] [Abstract][Full Text] [Related]
10. Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study. Kühlkamp V; Schirdewan A; Stangl K; Homberg M; Ploch M; Beck OA J Am Coll Cardiol; 2000 Jul; 36(1):139-46. PubMed ID: 10898425 [TBL] [Abstract][Full Text] [Related]
11. Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation. Capucci A; Piangerelli L; Ricciotti J; Gabrielli D; Guerra F Europace; 2016 Nov; 18(11):1698-1704. PubMed ID: 26893497 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation. Demircan C; Cikriklar HI; Engindeniz Z; Cebicci H; Atar N; Guler V; Unlu EO; Ozdemir B Emerg Med J; 2005 Jun; 22(6):411-4. PubMed ID: 15911947 [TBL] [Abstract][Full Text] [Related]
13. Cardiac responses to the intrapericardial delivery of metoprolol: targeted delivery compared to intravenous administration. Richardson ES; Rolfes C; Woo OS; Elmquist WF; Benditt DG; Iaizzo PA J Cardiovasc Transl Res; 2012 Aug; 5(4):535-40. PubMed ID: 21877256 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial. Beatch GN; Mangal B BMC Cardiovasc Disord; 2016 May; 16():113. PubMed ID: 27233239 [TBL] [Abstract][Full Text] [Related]
15. Combined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation. Verrier RL; Silva AF; Bonatti R; Batatinha JA; Nearing BD; Liu G; Rajamani S; Zeng D; Belardinelli L J Cardiovasc Electrophysiol; 2015 Mar; 26(3):329-35. PubMed ID: 25346368 [TBL] [Abstract][Full Text] [Related]
16. Metoprolol vs. diltiazem in the acute management of atrial fibrillation in patients with heart failure with reduced ejection fraction. Hirschy R; Ackerbauer KA; Peksa GD; O'Donnell EP; DeMott JM Am J Emerg Med; 2019 Jan; 37(1):80-84. PubMed ID: 29731345 [TBL] [Abstract][Full Text] [Related]